Clonidine: Difference between revisions

(3 intermediate revisions by the same user not shown)

Line 2:

'''Clonidine''' (known by the trade names '''Catapres''', '''Kapvay''', '''Nexiclon''', '''Clophelin''', and others) is a [[psychoactive class::depressant]] substance of the [[chemical class::~~imidazoline~~]] class. It is primarily used to treat [[increased blood pressure|high blood pressure]], but can also be used for a variety of conditions that include attention deficit hyperactivity disorder, [[anxiety]] disorders, tic disorders, [[drug withdrawal|substance withdrawal]], migraine, [[diarrhea]], and certain pain conditions.<ref>{{cite journal | veditors=((Soni, H.)), ((Brayfield, A.)) | journal=Pharmaceutical Press | title=“Clonidine”. Martindale: The Complete Drug Reference | volume=22 | issue=5 | pages=12–12 | date=13 January 2014 | url=http://rcnpublishing.com/doi/abs/10.7748/en.22.5.12.s13 | issn=1354-5752| doi=10.7748/en.22.5.12.s13 | access-date=28 June 2014}}</ref>

'''Clonidine''' (known by the trade names '''Catapres''', '''Kapvay''', '''Nexiclon''', '''Clophelin''', and others) is a [[psychoactive class::depressant]] substance of the [[chemical class::arylaminoimidazoline]] class. It is primarily used to treat [[increased blood pressure|high blood pressure]], but can also be used for a variety of conditions that include attention deficit hyperactivity disorder, [[anxiety]] disorders, tic disorders, [[drug withdrawal|substance withdrawal]], migraine, [[diarrhea]], and certain pain conditions.<ref>{{cite journal | veditors=((Soni, H.)), ((Brayfield, A.)) | journal=Pharmaceutical Press | title=“Clonidine”. Martindale: The Complete Drug Reference | volume=22 | issue=5 | pages=12–12 | date=13 January 2014 | url=http://rcnpublishing.com/doi/abs/10.7748/en.22.5.12.s13 | issn=1354-5752| doi=10.7748/en.22.5.12.s13 | access-date=28 June 2014}}</ref>

Developed by Boehringer Ingelheim for its blood pressure effects, clonidine first saw clinical use in 1966.<ref name="Stahle">{{cite journal | vauthors=((Stähle, H.)) | journal=Best Practice & Research Clinical Anaesthesiology | title=A historical perspective: development of clonidine | volume=14 | issue=2 | pages=237–246 | date= June 2000 | url=https://linkinghub.elsevier.com/retrieve/pii/S152168960090079X | issn=15216896 | doi=10.1053/bean.2000.0079}}</ref>

Line 159:

~~[[Category:Substance]]~~

[[Category:Psychoactive substance]]

[[Category:Depressant]]

[[Category:~~Imidazoline~~]]

[[Category:Arylaminoimidazoline]]

@@ Line 2: / Line 2: @@
 {{SubstanceBox/Clonidine}}
-'''Clonidine''' (known by the trade names '''Catapres''', '''Kapvay''', '''Nexiclon''', '''Clophelin''', and others) is a [[psychoactive class::depressant]] substance of the [[chemical class::imidazoline]] class. It is primarily used to treat [[increased blood pressure|high blood pressure]], but can also be used for a variety of conditions that include attention deficit hyperactivity disorder, [[anxiety]] disorders, tic disorders, [[drug withdrawal|substance withdrawal]], migraine, [[diarrhea]], and certain pain conditions.<ref>{{cite journal | veditors=((Soni, H.)), ((Brayfield, A.)) | journal=Pharmaceutical Press | title=“Clonidine”. Martindale: The Complete Drug Reference | volume=22 | issue=5 | pages=12–12 | date=13 January 2014 | url=http://rcnpublishing.com/doi/abs/10.7748/en.22.5.12.s13 | issn=1354-5752| doi=10.7748/en.22.5.12.s13 | access-date=28 June 2014}}</ref>
+'''Clonidine''' (known by the trade names '''Catapres''', '''Kapvay''', '''Nexiclon''', '''Clophelin''', and others) is a [[psychoactive class::depressant]] substance of the [[chemical class::arylaminoimidazoline]] class. It is primarily used to treat [[increased blood pressure|high blood pressure]], but can also be used for a variety of conditions that include attention deficit hyperactivity disorder, [[anxiety]] disorders, tic disorders, [[drug withdrawal|substance withdrawal]], migraine, [[diarrhea]], and certain pain conditions.<ref>{{cite journal | veditors=((Soni, H.)), ((Brayfield, A.)) | journal=Pharmaceutical Press | title=“Clonidine”. Martindale: The Complete Drug Reference | volume=22 | issue=5 | pages=12–12 | date=13 January 2014 | url=http://rcnpublishing.com/doi/abs/10.7748/en.22.5.12.s13 | issn=1354-5752| doi=10.7748/en.22.5.12.s13 | access-date=28 June 2014}}</ref>
 Developed by Boehringer Ingelheim for its blood pressure effects, clonidine first saw clinical use in 1966.<ref name="Stahle">{{cite journal | vauthors=((Stähle, H.)) | journal=Best Practice & Research Clinical Anaesthesiology | title=A historical perspective: development of clonidine | volume=14 | issue=2 | pages=237–246 | date= June 2000 | url=https://linkinghub.elsevier.com/retrieve/pii/S152168960090079X | issn=15216896 | doi=10.1053/bean.2000.0079}}</ref>
@@ Line 159: / Line 159: @@
 <references />
-[[Category:Substance]]
 [[Category:Psychoactive substance]]
 [[Category:Depressant]]
-[[Category:Imidazoline]]
+[[Category:Arylaminoimidazoline]]